Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

602
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

588
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
588
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

779
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
779
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into the mitochondrial genomes of Taenia tapeworms.

Molecular biology reports·2026
Same author

Energy restriction and iron supplementation improve iron status in women with obesity regardless of red meat consumption: a randomized controlled trial.

Scientific reports·2026
Same author

Pilot Trial of <i>Vachellia farnesiana</i> Pod Polyphenol Extract: Feasibility, Acute Postprandial Glycemic Response, and Incretin Hormone Modulation in Healthy Adults.

Current developments in nutrition·2026
Same author

Malondialdehyde as a Predictor of Disease Severity and Cardiovascular Risk in Population with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Metabolites·2026
Same author

Genomic and structural insights into TATA-Binding protein from cestodes.

Transcription·2026
Same author

Corrigendum to 'Modulation of ceramides through nutrition: A new target in obesity and insulin resistance (Narrative Review)' [Clin Nutr ESPEN 71 (2026) 102836].

Clinical nutrition ESPEN·2026

Related Experiment Video

Updated: Apr 11, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.1K

Nutrition and Atherosclerosis.

Nimbe Torres1, Martha Guevara-Cruz1, Laura A Velázquez-Villegas1

  • 1Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F., México.

Archives of Medical Research
|June 3, 2015
PubMed
Summary
This summary is machine-generated.

Dietary modifications are key to preventing atherosclerosis, a major cause of cardiovascular disease (CVD). Specific nutrients and foods can help manage atherosclerosis risk and support patient health.

Keywords:
Dietantioxidantscardiovascular diseasecholesterolnutrients

More Related Videos

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
03:35

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Published on: December 1, 2023

808
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.7K

Related Experiment Videos

Last Updated: Apr 11, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.1K
Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
03:35

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Published on: December 1, 2023

808
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.7K

Area of Science:

  • Nutrition Science
  • Cardiovascular Health
  • Preventive Medicine

Background:

  • Cardiovascular disease (CVD), particularly atherosclerosis, poses a significant global health challenge.
  • Diet is a modifiable factor crucial for preventing and managing noncommunicable diseases like atherosclerosis.
  • Nutritional strategies are increasingly recognized for their role in promoting health and intervening in disease processes.

Purpose of the Study:

  • To review the role of specific foods, nutrients, and bioactive compounds in preventing atherosclerosis.
  • To explore epidemiological evidence, mechanisms of action, and dietary recommendations for reducing atherosclerosis risk.
  • To examine the impact of gut microbiota and its metabolites on atherosclerosis development.

Main Methods:

  • Literature review of epidemiological, clinical, and experimental studies.
  • Analysis of the effects of fiber, plant sterols, niacin, taurine, olive oil, omega-3 fatty acids, antioxidants, minerals, methyl nutrients, and soy.
  • Investigation into the link between gut dysbiosis, animal food consumption, and atherosclerosis-promoting metabolites.

Main Results:

  • Dietary interventions focusing on specific nutrients and foods demonstrate a central role in atherosclerosis prevention.
  • Certain nutrients like fiber, plant sterols, niacin, taurine, olive oil, omega-3 fatty acids, and antioxidants show promise.
  • Intestinal microbiota dysbiosis, influenced by diet, can contribute to atherosclerosis development through specific metabolites.

Conclusions:

  • Dietary modification is a primary strategy for managing atherosclerosis and reducing CVD risk.
  • Specific dietary components and a balanced gut microbiota are essential for complementary clinical management of atherosclerosis.
  • Evidence supports recommendations for dietary foods, nutrients, and bioactive compounds to support cardiovascular health.